Do investigational MET inhibitors have potential for the treatment of gastric cancer?

被引：2
|
作者：
Athauda, Avani [1 ]
Chau, Ian [1 ]
机构：
[1] Royal Marsden Hosp NHS Fdn Trust, Gastrointestinal & Lymphoma Unit, Downs Rd, Sutton, Surrey, England
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2019年 / 28卷 / 04期
关键词：
MET; gastric cancer; biomarkers; receptor tyrosine kinase MET; GENE COPY NUMBER; DOUBLE-BLIND; AMPLIFICATION; ADENOCARCINOMA; RESISTANCE; EXPRESSION; SURVIVAL; THERAPY; CAPECITABINE; COMBINATION;
D O I：
10.1080/13543784.2019.1582641
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：299 / 302
页数：4
相关论文
共 50 条
  • [31] Do histone deacetylase inhibitors have a place in the treatment of myelodysplastic syndromes?
    Gore, S. D.
    LEUKEMIA RESEARCH, 2007, 31 : S21 - S21
  • [32] Investigational PARP inhibitors for the treatment of biliary tract cancer: spotlight on preclinical and clinical studies
    Mehta, Rutika
    Wood, Anthony C.
    Yu, James
    Kim, Richard
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (04) : 451 - 461
  • [33] Investigational CHK1 inhibitors in early phase clinical trials for the treatment of cancer
    Dent, Paul
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (12) : 1095 - 1100
  • [34] C-met as a therapeutic target for metastatic potential of gastric cancer.
    Cho, H.
    Zhang, X.
    Jung, M.
    Kwon, W.
    Jung, J.
    Jeung, H.
    Roh, J. K.
    Chung, H. C.
    Rha, S. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Do small RNAs have potential in disease diagnosis and treatment?
    Maan, Sushila
    Batra, Kanisht
    Maan, Narender Singh
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2021, 21 (06) : 527 - 529
  • [36] Characterization of Bozitinib as a potential therapeutic agent for MET-amplified gastric cancer
    Lin, Hang
    Qu, Lingzhi
    Wei, Hudie
    Guo, Ming
    Chen, Xiaojuan
    Lin, Qianmeng
    Zhang, Huajun
    Dai, Shuyan
    Chen, Yongheng
    COMMUNICATIONS BIOLOGY, 2025, 8 (01)
  • [37] Therapeutic Implications of mTOR Inhibitors in the Treatment of Gastric Cancer
    Bu, Zhaode
    Ji, Jiafu
    CURRENT CANCER DRUG TARGETS, 2013, 13 (02) : 121 - 125
  • [38] Potential role of rilotumumab in the treatment of gastric cancer
    Waddell, Tom
    Moorcraft, Sing Yu
    Cunningham, David
    IMMUNOTHERAPY, 2014, 6 (12) : 1243 - 1253
  • [39] Revolutionizing gastric cancer treatment: The potential of immunotherapy
    Christodoulidis, Grigorios
    Koumarelas, Konstantinos Eleftherios
    Kouliou, Marina Nektaria
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (04) : 286 - 289
  • [40] Therapeutic potential of lipin inhibitors for the treatment of cancer
    Slane, Elizabeth G.
    Tambrini, Samantha J.
    Cummings, Brian S.
    BIOCHEMICAL PHARMACOLOGY, 2024, 222
12345